Related Experiment Video
Updated: May 15, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[Correlation between Chlamydia pneumoniae infection and chronic obstructive pulmonary disease]
Liang-Fa Tang1, Dan-Feng Wang, Li-Qiang Cao
1Department of Respiratory Medicine of People's Hospital of Jiangyin, Jiangyin 214400, China. tangliangfa20@163.com
Summary
Chlamydia pneumoniae (Cpn) infection is closely linked to the development of chronic obstructive pulmonary disease (COPD). This study found higher Cpn antibody levels in COPD patients, suggesting a significant correlation.
Area of Science:
- Respiratory Medicine
- Infectious Diseases
- Microbiology
Context:
- Chronic obstructive pulmonary disease (COPD) is a major global health concern.
- The role of Chlamydia pneumoniae (Cpn) infection in COPD pathogenesis remains under investigation.
- Understanding infectious triggers is crucial for managing COPD exacerbations.
Purpose:
- To investigate the association between Chlamydia pneumoniae infection and chronic obstructive pulmonary disease.
- To compare Cpn antibody levels (IgG, IgM, IgA) in patients with acute exacerbation of COPD (AE-COPD), stable COPD, and healthy controls.
Summary:
- Serum samples from 82 AE-COPD/stable COPD patients and 38 healthy controls were analyzed for Cpn antibodies using micro-immunofluorescence.
- Elevated IgG geometric mean titers (GMT) were observed in AE-COPD patients compared to controls (P < 0.01).
- Higher IgA positive rates and GMT were found in AE-COPD and stable COPD groups compared to controls (P < 0.01), indicating both acute and chronic Cpn infections are more prevalent in COPD patients.
Impact:
- Findings suggest a significant correlation between Chlamydia pneumoniae infection and the development and exacerbation of COPD.
- This research may inform future diagnostic and therapeutic strategies targeting Cpn in COPD management.
- Highlights the importance of considering infectious agents in the multifactorial etiology of COPD.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...